TickerFacts.

Axim Biotechnologies, Inc. (AXIM): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$2.32M
Year ended 2023-12-31
2014-12-31: -$505.7K2015-12-31: -$10.05M2016-12-31: -$3.76M2020-12-31: -$4.93M2021-12-31: -$11.86M2022-12-31: -$4.23M2023-12-31: -$2.32M-$2.32M
2014-12-31 EBITDA (USD) 2023-12-31
Period endedEBITDAChange YoYSource filing
2023-12-31-$2.32Mn/m2024-04-16, From 2023-01-01
2022-12-31-$4.23Mn/m2024-04-16, From 2022-01-01
2021-12-31-$11.86Mn/m2023-04-17, From 2021-01-01
2020-12-31-$4.93Mn/a2022-04-19, From 2020-01-01
No annual figure between 2016-12-31 and 2020-12-31.
2016-12-31-$3.76Mn/m2018-03-15, From 2016-01-01
2015-12-31-$10.05Mn/m2017-09-14, From 2015-01-01
2014-12-31-$505.7Kn/a2016-04-18, From 2014-01-01